WST Financial Facts
Operating profit: 51.3MResearch and development: 9M
See Full Income Statement
Accrued salaries, wages and benefits: 58.9M
Other current liabilities: 67.4M
See Full Balance Sheet
West Pharmaceutical Services, Inc. (WST) Earnings
|
Expand Research on WST
| Next EPS Date | 7/25/24 *Est. | EPS Growth Rate | -21.2% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +11.9% | Revenue Growth Rate | -3.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -8.0% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4/25/24 | Q124 | $1.56 | $1.30 | +$0.26 | $695.4M | $670.31M | = |  | | Details | |
| 2/15/24 | Q423 | $1.83 | $1.78 | +$0.05 | $732M | $739.46M | = | | | Details | |
| 10/26/23 | Q323 | $2.16 | $1.86 | +$0.30 | $747.4M | $749.89M | = | | | Details | |
| 7/27/23 | Q223 | $2.11 | $1.94 | +$0.17 | $753.8M | $757.43M | = | | | Details | |
| 4/27/23 | Q123 | $1.98 | $1.65 | +$0.33 | $716.6M | $691.67M | = | | | Details | |
| 2/16/23 | Q422 | $1.77 | $1.37 | +$0.40 | $708.7M | $657.17M | = | | | Details | |
| 10/27/22 | Q322 | $2.03 | $2.13 | -$0.10 | $686.9M | $728.11M | = | | | Details | |
| 7/28/22 | Q222 | $2.48 | $2.21 | +$0.27 | $771.3M | $755.08M | = | | | Details |
